Philips报告2025年Q1销售量下降,但随着北美销售额的强劲,蚊帐利润增长。 Philips reports Q1 2025 sales dip, but nets profit growth with strong North American sales.

2025年,菲利浦公司报告可比销售额下降2%,主要原因是中国大幅下降,但净利润回报和订单摄入量增长,主要受北美和个人健康驱动。 In Q1 2025, Philips reported a 2% decline in comparable sales, largely due to a significant drop in China, but saw a net profit return and order intake growth, mainly driven by North America and Personal Health. 尽管诊断、治疗和连线护理部分有所下降,但个人健康销售额上升了1%。 Despite a decline in Diagnosis & Treatment and Connected Care segments, Personal Health sales rose 1%. 该公司强调了AI公司在成像和病人监测伙伴关系方面的创新,同时面临关税不确定性,并调整了EBITA的比值前景。 The company highlighted innovations in AI for imaging and partnerships for patient monitoring, while facing tariff uncertainties and adjusting its EBITA margin outlook.